E Trademark

Trademark Overview


On Thursday, July 14, 2022, a trademark application was filed for E with the United States Patent and Trademark Office. The USPTO has given the E trademark a serial number of 97503170. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, June 24, 2024. This trademark is owned by Elenae Therapeutics, Inc.. The E trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medical therapeutic preparations, namely, antisense therapeutics; therapeutics in the nature of pharmaceuticals for treatment of Duchenne Muscular Dystrophy (DMD)

research and development of gene therapeutics, namely, antisense therapeutics; research and development of anti-miRNA technology for the treatment of Duchenne Muscular Dystrophy (DMD); research and development of therapeutics for treatment of Duchenne Muscular Dystrophy (DMD); pharmaceutical and therapeutic research and development
e

General Information


Serial Number97503170
Word MarkE
Filing DateThursday, July 14, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateMonday, June 24, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 2, 2023

Trademark Statements


Description of MarkThe mark consists of a stylized helix shaped design forming the letter "e".
Goods and ServicesMedical therapeutic preparations, namely, antisense therapeutics; therapeutics in the nature of pharmaceuticals for treatment of Duchenne Muscular Dystrophy (DMD)
Pseudo MarkELENAE
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesresearch and development of gene therapeutics, namely, antisense therapeutics; research and development of anti-miRNA technology for the treatment of Duchenne Muscular Dystrophy (DMD); research and development of therapeutics for treatment of Duchenne Muscular Dystrophy (DMD); pharmaceutical and therapeutic research and development

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 3, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElenae Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94704

Party NameElenae Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94704

Trademark Events


Event DateEvent Description
Monday, July 18, 2022NEW APPLICATION ENTERED
Wednesday, August 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 4, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 23, 2023ASSIGNED TO EXAMINER
Monday, March 27, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, March 27, 2023EXAMINERS AMENDMENT E-MAILED
Monday, March 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 27, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, March 27, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, April 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 2, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 2, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 27, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 14, 2023SOU TEAS EXTENSION RECEIVED
Thursday, December 14, 2023SOU EXTENSION 1 FILED
Thursday, December 14, 2023SOU EXTENSION 1 GRANTED
Saturday, December 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 23, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 23, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, June 24, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 24, 2024SOU EXTENSION 2 GRANTED
Monday, June 24, 2024SOU EXTENSION 2 FILED